FIELD: medicine.
SUBSTANCE: invention relates to a chemico-pharmaceutical industry, and concerns the solid pharmaceutical composition containing water-soluble salts of levothyroxine and-or liothyroninum as an active substance where water activity is set equal to less than 0.4 at measurement at a room temperature. The composition with 0.4 water activity or less possesses high stability at storage.
EFFECT: development of a composition which possesses high stability at storage.
18 cl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION | 1999 |
|
RU2225711C2 |
| WATER-SOLUBLE TABLETS OF COLECALCIFEROL AND METHOD FOR THEIR PRODUCTION | 2022 |
|
RU2796676C1 |
| THYROID HORMONE-CONTAINING PHARMACEUTICAL COMPOSITION | 2002 |
|
RU2205003C1 |
| METHOD FOR PRODUCING INSTANT FORMULATION OF FURACILIN (OPTIONAL) | 2014 |
|
RU2578456C1 |
| MEANS FOR ISCHEMIA TREATMENT, METHOD FOR ITS PRODUCTION AND METHOD FOR ISCHEMIA TREATMENT (VERSIONS) | 2015 |
|
RU2620163C2 |
| ANTACID AND METHODS FOR PRODUCING IT (VERSIONS) | 2013 |
|
RU2567800C2 |
| SILANZETRON PHARMACEUTICAL MEDICINAL FORMS STABILIZED IN REGARD TO RACEMIZATION | 1998 |
|
RU2199318C2 |
| RAPIDLY DISSOLVING PHARMACEUTICAL FORM OF INDOMETHACIN AND METHOD FOR PRODUCTION THEREOF (VARIANTS) | 2020 |
|
RU2764032C1 |
| SOLID RAPIDLY DEGRADING SPARKLING COMPOSITION FOR ORAL ADMINISTRATION AND A METHOD FOR PREPARATION THEREOF | 1999 |
|
RU2221554C2 |
| HARD, SUITABLE FOR ORAL INTAKE PHARMACEUTICAL FORMS OF APPLICATION, CONTAINING RIVAROXABAN WITH MODIFIED RELEASE | 2005 |
|
RU2420290C2 |
